TRENDING NEWS
  • Germany forecasts tourism surge during UEFA Euro 2024
  • Modi urges toursits to spend 105 of their travel budget to purchase local goods
  • Kerala to undertake intiatives to promote the state as global meeting veue
  • Swiss cancels plans for domestic A340 this summer
  • Scandron receives DGCA logistics drone certificate
  • Air India, Tata Advanced System to invest INR 2,300cr in Karnataka
  • Plan is to bring Air India on the same level as Vistara: CEO

Hope to Resolve Issues Faced by Indians Vaccinated with Covishield Travelling to EU Soon: Poonawalla

Adar Poonawalla, Chief Executive Officer, Serum Institute of India said he has taken up the issues faced by Indians who have taken the Covishield jab travelling to the European Union at highest levels and hoped to resolve them soon. Covishield is the Oxford University-AstraZeneca vaccine manufactured in India by the Pune-based vaccine maker.

“I realise that a lot of Indians who have taken Covishield are facing issues with travel to the EU, I assure everyone, I have taken this up at the highest levels and hope to resolve this matter soon, both with regulators and at a diplomatic level with countries,” Poonawalla said in a tweet. As of now European Union (EU) recognises Vaxzevria (previously COVID-19 Vaccine AstraZeneca, Oxford).

The other vaccines approved by the European Medicine Agency are Comirnaty by BioNTech-Pfizer, Moderna and Janssen (Johnson & Johnson). (Source: News18)

 

Read Previous

Vietnam’s Ha Long Bay to reduce quarantine for vaccinated foreign tourists

Read Next

FM announces financial support to over 11,000 registered tourist guides, stakeholders to revive tourism sector

Most Popular

Download Magazine